Related Experiment Video
Updated: May 22, 2025

Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF1
Published on: February 28, 2025
Aberrant macrophage activation and maladaptive lung repair promote tuberculosis progression uniquely in the lung
Shivraj M Yabaji1, Suruchi Lata1, Anna E Tseng1
1The National Emerging Infectious Diseases Laboratories (NEIDL), Boston University.
Abstract:
Pulmonary tuberculosis (PTB) represents 85% of the disease burden caused by Mycobacterium tuberculosis (Mtb) and promotes aerosol transmission infecting about a quarter of people globally. Most Mtb infections are effectively limited within primary granulomatous lesions. Containment failures lead to hematogenous spread and the formation of post-primary destructive PTB lesions. Factors that favor Mtb survival and replication in the lungs after hematogenous spread despite systemic immunity represent appealing targets for host-directed TB therapies, but are currently unknown. We developed a novel mouse model that mimics progression of chronic post-primary PTB in humans: wherein PTB lesions form after hematogenous spread from a remote primary lesion in immunocompetent but TB-susceptible B6.Sst1S mice. The B6.Sst1S mice developed PTB lesions featuring granulomatous pneumonia, bronchogenic expansion and broncho-occlusion closely resembling post-primary PTB in humans. Using spatial transcriptomic and fluorescent multiplexed immunochemistry, we demonstrated the expansion of myeloid cell populations with the appearance of alternatively activated macrophages, dissolution of initial lymphoid follicles, and accumulation of de-differentiated lung epithelial cells in the advanced PTB lesions. To determine whether lung parenchymal cells or lung oxygenation were necessary for the pulmonary TB progression, we implanted lung and spleen fragments subcutaneously to serve as potential targets for hematogenous spread. The lung (but not spleen) implants displayed characteristic organized granulomas with necrosis and Mtb replication demonstrating that deleterious interactions of aberrantly activated macrophages with the inflammation-injured lung resident cells, and possibly hypoxia, not oxygenation, are critical determinants of PTB progression in immunocompetent hosts. Necrotic TB lesions also developed in subcutaneous implants of human lung tissue in mice with human immune system after respiratory infection. These animal models may serve to further dissect the lung-specific mechanisms of host susceptibility to virulent Mtb and for testing therapeutic interventions targeting these mechanisms.
Insights
Researchers developed a new mouse model for post-primary pulmonary tuberculosis (PTB). This model reveals that lung cells and hypoxia, not oxygen levels, drive Mtb progression in immunocompetent hosts.
Area of Science:
- Immunology
- Infectious Diseases
- Pulmonology
Background:
- Pulmonary tuberculosis (PTB) is caused by Mycobacterium tuberculosis (Mtb) and leads to significant global health burden.
- Mtb infections are usually contained in granulomas, but failure can cause destructive post-primary PTB lesions.
- Understanding factors driving Mtb survival in the lungs is crucial for developing host-directed therapies.
Purpose of the Study:
- To develop a novel mouse model mimicking chronic post-primary PTB in humans.
- To identify key determinants of Mtb replication and lesion progression in the lung.
- To explore the role of lung parenchymal cells and oxygenation in PTB pathogenesis.
Main Methods:
- Developed a B6.Sst1S mouse model for post-primary PTB following hematogenous spread.
- Utilized spatial transcriptomics and multiplexed immunochemistry to analyze lesion pathology.
- Implanted lung and spleen fragments subcutaneously to assess Mtb tropism and lesion development.
Main Results:
- The mouse model recapitulated human post-primary PTB features, including granulomatous pneumonia and bronchogenic spread.
- Advanced lesions showed myeloid cell expansion, alternatively activated macrophages, and de-differentiated lung epithelial cells.
- Subcutaneous lung implants, but not spleen implants, developed necrotic granulomas with Mtb replication, indicating lung-specific susceptibility.
Conclusions:
- Lung parenchymal cells and hypoxia, rather than oxygenation, are critical for PTB progression in immunocompetent hosts.
- Aberrant macrophage interactions with inflammation-injured lung cells drive Mtb replication.
- The developed models are valuable for dissecting lung-specific Mtb susceptibility and testing new TB therapies.
More Related Videos
10:10A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
Published on: October 5, 2015
10:43Polarization of M1 and M2 Human Monocyte-Derived Cells and Analysis with Flow Cytometry upon Mycobacterium tuberculosis Infection
Published on: September 18, 2020
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...